PRINCIPAL FINANCIAL GROUP INC - LEXICON PHARMACEUTICALS INC ownership

LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 112 filers reported holding LEXICON PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.53 and the average weighting 1.0%.

Quarter-by-quarter ownership
PRINCIPAL FINANCIAL GROUP INC ownership history of LEXICON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$11,263
-52.4%
10,3330.0%0.00%
Q2 2023$23,663
-76.0%
10,333
-74.5%
0.00%
Q1 2023$98,523
+25.2%
40,544
-1.6%
0.00%
Q4 2022$78,713
+228.0%
41,211
+311.9%
0.00%
Q3 2022$24,000
-77.8%
10,006
-80.7%
0.00%
Q1 2022$108,000
-61.3%
51,855
-26.7%
0.00%
Q4 2021$279,000
-70.0%
70,789
-63.4%
0.00%
-100.0%
Q3 2021$930,000
+1.6%
193,412
-2.9%
0.00%0.0%
Q2 2021$915,000
-14.2%
199,282
+9.6%
0.00%0.0%
Q1 2021$1,067,000
+84.9%
181,862
+7.8%
0.00%
Q4 2020$577,000
+205.3%
168,636
+28.3%
0.00%
Q3 2020$189,000
+37.0%
131,435
+89.8%
0.00%
Q2 2020$138,000
+193.6%
69,239
+339.2%
0.00%
Q3 2019$47,000
-53.9%
15,765
-3.1%
0.00%
Q2 2019$102,000
+17.2%
16,274
+3.8%
0.00%
Q1 2019$87,000
-13.9%
15,671
+3.1%
0.00%
Q4 2018$101,000
-42.0%
15,193
-6.7%
0.00%
Q3 2018$174,000
-6.5%
16,282
+5.0%
0.00%
Q2 2018$186,000
+14.1%
15,509
-18.3%
0.00%
Q1 2018$163,000
-4.7%
18,977
+9.7%
0.00%
Q4 2017$171,000
-47.4%
17,297
-23.7%
0.00%
Q1 2017$325,000
+3.8%
22,684
+0.3%
0.00%
Q4 2016$313,000
+251.7%
22,614
+104.4%
0.00%
Q2 2015$89,00011,0650.00%
Other shareholders
LEXICON PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Ulys, L.L.C. 4,321,214$62,009,000100.00%
Artal Group S.A. 57,517,977$825,383,00017.04%
NEA Management Company, LLC 2,382,286$34,186,0001.77%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 35,714$512,0001.49%
BRIDGER MANAGEMENT, LLC 1,029,926$14,779,0000.95%
FALCON POINT CAPITAL, LLC 287,809$4,130,0000.71%
HANCOCK WHITNEY CORP 664,025$9,529,0000.40%
KINGDON CAPITAL MANAGEMENT, L.L.C. 494,380$7,094,0000.39%
ELLINGTON MANAGEMENT GROUP LLC 11,700$168,0000.23%
Convergence Investment Partners, LLC 114,157$1,638,0000.22%
View complete list of LEXICON PHARMACEUTICALS INC shareholders